Dynamic competition in pharmaceuticals: Patent expiry, generic penetration, and industry structure

Author： Magazzini Laura Pammolli Fabio Riccaboni Massimo

ISSN： 1618-7598

Source： The European Journal of Health Economics, Vol.5, Iss.2, 2004-05, pp. : 175-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Side effects of generic competition?

By Hellström Jörgen Rudholm Niklas

The European Journal of Health Economics, Vol. 5, Iss. 3, 2004-09 ,pp. : 203-208

Springer Publishing Company

Access to resources Recommend Favorite

OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS

International Journal of Technology Assessment in Health Care, Vol. 32, Iss. 6, 2017-01 ,pp. : 385-392

Cambridge University Press

Access to resources Recommend Favorite

Pioneering advantage in generic drug competition

By Yu Yu Gupta Sachin

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 8, Iss. 2, 2014-05 ,pp. : 126-150

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Price regulation and generic competition in the pharmaceutical market

By Dalen Dag Strøm Steinar Haabeth Tonje

The European Journal of Health Economics, Vol. 7, Iss. 3, 2006-09 ,pp. : 204-211

Springer Publishing Company

Access to resources Recommend Favorite

The impact of generic substitution on price competition in Finland

By Aalto-Setälä Ville

The European Journal of Health Economics, Vol. 9, Iss. 2, 2008-05 ,pp. : 185-191

Springer Publishing Company

Access to resources Recommend Favorite